MSF Science Portal
My saved items
Conference Material > Video
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
Fahal AH
Share
Linked Items
Share
Video
Countries
Sudan
Subject Area
neglected tropical diseases
surgery & trauma care
antimicrobial resistance
DOI
10.57740/GQiuyzt6H
Published Date
16-May-2024
Languages
English
Conference
MSF Scientific Day International 2024
Linked Items
Conference Material > Abstract
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
16-May-2024
Conference Material > Slide Presentation
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
16-May-2024
